Since 1995, Reliable Business Intelligence for Clinical Laboratories, Pathology Groups and Laboratory Diagnostics

Search

Search Results for: COVID-19

How Is COVID-19 Evolving? It’s Not Like Flu or Colds

CEO SUMMARY: It’s been 53 months since the SARS-CoV-2 virus triggered the worst global pandemic since 1918’s influenza pandemic. The coronavirus continues to surprise public health officials as new variants are detected, along with a multi-year pattern of summer surges in new cases. The pandemic made wastewater testing an essential tool for public health officials […]

To access this post, you must purchase The Dark Report.

How Is COVID-19 Evolving? It’s Not Like Flu or Colds Read More »

Despite COVID-19 Losses, IVD Executives Remain Upbeat

Continuing declines in COVID-19 test revenues was a common theme during the first quarter 2023 earning reports released by the nation’s largest in vitro diagnostics (IVD) manufacturers. At the same time, there was optimism as different IVD firms highlighted advancement and business opportunities in the following areas: • Digital pathology. • Companion diagnostics. • New

To access this post, you must purchase The Dark Report.

Despite COVID-19 Losses, IVD Executives Remain Upbeat Read More »

Newsmaker Interview: Director of CDC’s Division of Laboratory Systems Talks COVID-19, CLIA, and More

CEO SUMMARY: In this exclusive interview, Reynolds Salerno, PhD, the Director of the Division of Laboratory Systems at the CDC, offers insightful comments about the federal agency’s response to the SARS-CoV-2 pandemic, what went right during public health efforts, and lessons that were learned. He also discusses how labs have dealt with the recent monkeypox

To access this post, you must purchase The Dark Report.

Newsmaker Interview: Director of CDC’s Division of Laboratory Systems Talks COVID-19, CLIA, and More Read More »

Thermo Fisher Expands Menu to Offset COVID-19 Decreases

IT’S NOT JUST CLINICAL LABORATORIES seeking ways to repurpose the analyzers and automation they used to perform SARS-CoV-2 testing. As the pandemic continues to ease, some in vitro diagnostics (IVD) companies want to help their lab customers by expanding the types of diagnostic tests than can be run on these instrument systems.  This is true

To access this post, you must purchase The Dark Report.

Thermo Fisher Expands Menu to Offset COVID-19 Decreases Read More »

In Post-COVID-19 Market, IVD Manufacturers Face Supply, Staff Challenges

CEO SUMMARY: After making billions during the COVID-19 pandemic, in vitro diagnostics (IVD) manufacturers must now adjust their strategies and relationships with clinical laboratory customers. Because many contracts for automated instruments are coming due, some IVD companies have the opportunity to grab additional market share at the expense of their competitors. IVD firms are also

To access this post, you must purchase The Dark Report.

In Post-COVID-19 Market, IVD Manufacturers Face Supply, Staff Challenges Read More »

Amazon to Close Employee COVID-19 Testing Lab in Ky.

IN A MOVE THAT MAY SURPRISE SOME OBSERVERS, Amazon announced it will close its COVID-19 employee testing laboratory in Hebron, Ky., which is just across the Ohio River from Cincinnati.  This is the second large COVID-19 clinical laboratory to publicly announce it will cease operations instead of transitioning to conduct other non-COVID testing for either

To access this post, you must purchase The Dark Report.

Amazon to Close Employee COVID-19 Testing Lab in Ky. Read More »

Labs Can Expect COVID-19 Lab Testing Audits and Federal Investigations

This is an excerpt of a 2,081-word article in the May 16, 2022 issue of  THE DARK REPORT. The full article is available to members of The Dark Intelligence Group. CEO SUMMARY: Billions of federal dollars were paid out for needed SARS-CoV-2 testing during the pandemic. Now, even the best-run clinical laboratories and pathology groups

To access this post, you must purchase The Dark Report.

Labs Can Expect COVID-19 Lab Testing Audits and Federal Investigations Read More »

Labs Can Expect COVID-19 Test Audits, Investigations

  CEO SUMMARY: Billions of federal dollars were paid out for needed SARS-CoV-2 testing during the pandemic. Now, even the best-run clinical laboratories and pathology groups may have compliance matters to address during upcoming government audits, according to healthcare attorney Matthew Murer. Some sites— including pop-up COVID-19 testing labs—are already feeling the sting of federal

To access this post, you must purchase The Dark Report.

Labs Can Expect COVID-19 Test Audits, Investigations Read More »

California Cancels COVID-19 Test Contract with PerkinElmer

CALIFORNIA HAS SHED MORE LIGHT ON THE DECISION to terminate PerkinElmer’s valuable contract to run the Valencia Branch Laboratory (VBL). The lab has been embroiled in controversy for much of its existence.  The state noted that SARS-CoV-2 testing options for the public played a large part in ending the contract. PerkinElmer notified the U.S. Securities

To access this post, you must purchase The Dark Report.

California Cancels COVID-19 Test Contract with PerkinElmer Read More »

IVD Firms Grow During 2022, but COVID-19 Revenue Dropped

MOST MAJOR IN VITRO DIAGNOSTICS (IVD) MANUFACTURERS started strong in 2022 as their base businesses regained steam and made up for the significant falloff in COVID-19 diagnostic test revenue.  During first quarter 2022 earnings calls with investors, leaders at publicly traded IVD companies said clinical laboratories are interested in expanding test menus on technology platforms

To access this post, you must purchase The Dark Report.

IVD Firms Grow During 2022, but COVID-19 Revenue Dropped Read More »

;